Investigators focused on the development of a universal influenza B virus vaccine based on the lipid nanoparticle-encapsulated nucleoside-modified mRNA platform.
[Nature Communications]
Home Newsletters Immunology of Infectious Disease News Development of a Pentavalent Broadly Protective Nucleoside-Modified mRNA Vaccine against Influenza B...
